Carregant...
Breast Cancer Risk in Relation to the Interval Between Menopause and Starting Hormone Therapy
BACKGROUND: Although breast cancer risk is greater in users of estrogen–progestin than estrogen-only formulations of menopausal hormonal therapy, reports on their effects have been somewhat inconsistent. We investigated whether the timing of these therapies affected breast cancer incidence. METHODS:...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2011
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3039726/ https://ncbi.nlm.nih.gov/pubmed/21278356 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djq527 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|